Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The North American Thrombosis Foundation (NATF) is a multidisciplinary non-profit organization dedicated to improving patient care and outcomes through education, research, and advocacy regarding thrombotic and cardiovascular diseases. Founded by leading clinicians and researchers, NATF focuses on increasing awareness of conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation. The organization provides extensive resources for both healthcare professionals and patients, including clinical guidelines, educational webinars, and support programs. NATF also supports research initiatives aimed at advancing the prevention and treatment of blood clots and related vascular conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North American Thrombosis Foundation.